Načítá se...
New drug developments in metastatic gastric cancer
Metastatic gastric cancer is associated with a poor prognosis and novel treatment options are desperately needed. The development of targeted therapies heralded a new era for the management of metastatic gastric cancer, however results from clinical trials of numerous targeted agents have been mixed...
Uloženo v:
| Vydáno v: | Therap Adv Gastroenterol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6236851/ https://ncbi.nlm.nih.gov/pubmed/30455742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284818808072 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|